GO
Loading...

Roche Pharma CEO on Alexion deal rumors

Thursday, 25 Jul 2013 | 2:25 AM ET

Daniel O'Day, CEO of Roche's pharma unit, declines to comment on Alexion deal talks, but says the company is keen on incorporating innovations into its portfolio.